CURIE DX LABORATORY LLC
NPI 1750047049
Clinical Medical Laboratory in Richardson, TX
NPI Status: Active since November 11, 2021
Contact Information
833 E ARAPAHO RD STE 102
RICHARDSON, TX
ZIP 75081
Phone: (618) 881-2522
- Organization
- Clinical Medical Laboratory
About CURIE DX LABORATORY LLC
This page provides the complete NPI Profile along with additional information for Curie Dx Laboratory Llc, a provider established in Richardson, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1750047049 assigned on November 2021. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 5 years ago. The authorized official of this NPI record is Jagadeshwar Porandla (President)
- NPI
- 1750047049
- Provider Name
- CURIE DX LABORATORY LLC
- Entity Type
- Organization
- Location Address
- 833 E ARAPAHO RD STE 102 RICHARDSON, TX 75081
- Location Phone
- (618) 881-2522
- Mailing Address
- 833 E ARAPAHO RD STE 102 RICHARDSON, TX 75081
- Mailing Phone
- (618) 881-2522
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 11-11-2021
- Last Update Date
- 11-17-2021
- Code Navigator
Establishments like Curie Dx Laboratory Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Additional Identifiers
The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.
| Identifier | Type / Code | Identifier State | Identifier Issuer |
|---|---|---|---|
| 45D2237484 | MEDICAID (05) | TX |
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
This is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.
This service was performed 179 times for 35 patientsThis test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.
This service was performed 38 times for 24 patientsThis test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.
This service was performed 38 times for 24 patientsA detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.
This service was performed 38 times for 24 patientsThis test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.
This service was performed 38 times for 24 patientsThis test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.
This service was performed 38 times for 24 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 266 times for 24 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 38 times for 24 patientsGene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.
This service was performed 11 times for 11 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 397 times for 129 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 175 times for 33 patientsReviews for CURIE DX LABORATORY LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1750047049, we treat the final digit (9) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 51. The final step is to find the difference between that total and the next multiple of ten (60 - 51 = 9).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 51 is 60. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1750047049, enumerated as an "organization" on November 11, 2021.
The provider is located at 833 E ARAPAHO RD STE 102 RICHARDSON, TX 75081 and the phone number is (618) 881-2522.
Clinical Medical Laboratory with taxonomy code 291U00000X.
The provider might be accepting Accepts: Medicare and Medicaid. Please consult your insurance carrier or call the provider to verify.
